S&P 500   4,576.79 (+0.85%)
DOW   35,175.08 (+1.72%)
QQQ   383.54 (+0.11%)
AAPL   165.77 (+2.43%)
MSFT   322.63 (-0.12%)
FB   314.29 (+2.43%)
GOOGL   2,837.20 (-0.10%)
AMZN   3,414.38 (+0.73%)
TSLA   982.80 (-3.17%)
NVDA   293.67 (-4.32%)
BABA   120.23 (+7.39%)
NIO   32.19 (+0.12%)
CGC   10.02 (+0.30%)
AMD   136.48 (-5.23%)
GE   96.30 (+3.81%)
MU   81.88 (+0.32%)
T   23.72 (+1.11%)
F   19.28 (+0.73%)
DIS   150.35 (+2.82%)
PFE   52.46 (-3.34%)
AMC   29.05 (+0.14%)
ACB   5.91 (+1.55%)
BA   206.10 (+3.83%)
S&P 500   4,576.79 (+0.85%)
DOW   35,175.08 (+1.72%)
QQQ   383.54 (+0.11%)
AAPL   165.77 (+2.43%)
MSFT   322.63 (-0.12%)
FB   314.29 (+2.43%)
GOOGL   2,837.20 (-0.10%)
AMZN   3,414.38 (+0.73%)
TSLA   982.80 (-3.17%)
NVDA   293.67 (-4.32%)
BABA   120.23 (+7.39%)
NIO   32.19 (+0.12%)
CGC   10.02 (+0.30%)
AMD   136.48 (-5.23%)
GE   96.30 (+3.81%)
MU   81.88 (+0.32%)
T   23.72 (+1.11%)
F   19.28 (+0.73%)
DIS   150.35 (+2.82%)
PFE   52.46 (-3.34%)
AMC   29.05 (+0.14%)
ACB   5.91 (+1.55%)
BA   206.10 (+3.83%)
S&P 500   4,576.79 (+0.85%)
DOW   35,175.08 (+1.72%)
QQQ   383.54 (+0.11%)
AAPL   165.77 (+2.43%)
MSFT   322.63 (-0.12%)
FB   314.29 (+2.43%)
GOOGL   2,837.20 (-0.10%)
AMZN   3,414.38 (+0.73%)
TSLA   982.80 (-3.17%)
NVDA   293.67 (-4.32%)
BABA   120.23 (+7.39%)
NIO   32.19 (+0.12%)
CGC   10.02 (+0.30%)
AMD   136.48 (-5.23%)
GE   96.30 (+3.81%)
MU   81.88 (+0.32%)
T   23.72 (+1.11%)
F   19.28 (+0.73%)
DIS   150.35 (+2.82%)
PFE   52.46 (-3.34%)
AMC   29.05 (+0.14%)
ACB   5.91 (+1.55%)
BA   206.10 (+3.83%)
S&P 500   4,576.79 (+0.85%)
DOW   35,175.08 (+1.72%)
QQQ   383.54 (+0.11%)
AAPL   165.77 (+2.43%)
MSFT   322.63 (-0.12%)
FB   314.29 (+2.43%)
GOOGL   2,837.20 (-0.10%)
AMZN   3,414.38 (+0.73%)
TSLA   982.80 (-3.17%)
NVDA   293.67 (-4.32%)
BABA   120.23 (+7.39%)
NIO   32.19 (+0.12%)
CGC   10.02 (+0.30%)
AMD   136.48 (-5.23%)
GE   96.30 (+3.81%)
MU   81.88 (+0.32%)
T   23.72 (+1.11%)
F   19.28 (+0.73%)
DIS   150.35 (+2.82%)
PFE   52.46 (-3.34%)
AMC   29.05 (+0.14%)
ACB   5.91 (+1.55%)
BA   206.10 (+3.83%)
NASDAQ:CUBT

Curative Biotechnology News Headlines

$0.06
-0.01 (-7.69%)
(As of 12/3/2021 03:55 PM ET)
Add
Compare
Today's Range
$0.05
$0.07
50-Day Range
$0.06
$0.12
52-Week Range
$0.03
$0.22
Volume
1.10 million shs
Average Volume
1.53 million shs
Market Capitalization
$32.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
-32.55

Media Mentions By Week



Curative Biotechnology Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CUBT
News Sentiment

0.00

0.35

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CUBT Articles
This Week

0

0

CUBT Articles
Average Week

Get Curative Biotechnology News Delivered to You Automatically

Sign up to receive the latest news and ratings for CUBT and its competitors with MarketBeat's FREE daily newsletter.

Curative Biotechnology (NASDAQ:CUBT) News Headlines Today

SourceHeadline
finance.yahoo.com logo[UPDATED] CURATIVE BIOTECHNOLOGY ANNOUNCES OCULAR TOLERANCE EVALUATION OF METFORMIN EYE DROP FORMULATIONS FOR TREATMENT OF MACULAR DEGENERATION
finance.yahoo.com - November 24 at 3:29 PM
finance.yahoo.com logoCURATIVE BIOTECHNOLOGY ANNOUNCES OCULAR TOLERANCE EVALUATION OF METFORMIN EYE DROP FORMULATIONS FOR TREATMENT OF MACULAR DEGENERATION
finance.yahoo.com - November 24 at 10:28 AM
MarketBeat logoCritical Comparison: Curative Biotechnology (NASDAQ:CUBT) versus Fresenius Medical Care AG & Co. KGaA (NYSE:FMS)
americanbankingnews.com - November 16 at 1:20 AM
finance.yahoo.com logoCURATIVE BIOTECHNOLOGY ANNOUNCES DR. CATHERINE SOHN AS SPECIAL ADVISOR TO BOARD AND CEO
finance.yahoo.com - October 12 at 12:33 PM
finance.yahoo.com logoCURATIVE BIOTECHNOLOGY ANNOUNCES IMT504 LICENSE FOR DEVELOPMENT OF PROPRIETARY NEXT-GEN COVID-19 VACCINE
finance.yahoo.com - October 7 at 1:18 PM
in.finance.yahoo.com logoCasePacer Announces Special Pricing for Mobile Plaintiff Discovery App
in.finance.yahoo.com - July 17 at 8:23 AM
au.finance.yahoo.com logoBayer Once Again Earns Top Marks in 2021 Disability Equality Index
au.finance.yahoo.com - July 16 at 5:54 PM
finance.yahoo.com logoCurative Biotechnology, Inc. Appoints Marc Drimer, CPA to Board of Directors as Independent Director and Chairman of Audit Committee
finance.yahoo.com - July 15 at 3:04 PM
Get Curative Biotechnology News Delivered to You Automatically

Sign up to receive the latest news and ratings for CUBT and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 12/6/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.